glp-1 - weight loss postbiotic reviews – Blackhawk Nutrition Long-term Success of GLP-1s Hinges

Clinicians need more resources like this to make informed decisions on these powerful drugs

Key highlights Retatrutide is a next-generation weight loss medication that activates GLP-1, GIP, and glucagon receptors simultaneously to promote appetite suppression, improve metabolic health, and increase energy expenditure

The authors noted this is an off-label strategy and called for controlled trials to validate effectiveness and define who might benefit

To gain access to the data, a request can be made to TriNetX ([email protected]), but costs might be incurred, and a data-sharing agreement would be necessary

Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo

doi: 10.1007/BF00429703 13 BuchanAMPolakJMCapellaCSolciaEPearseAG